782016001: Product containing precisely glycopyrronium bromide 500 microgram/1 milliliter and neostigmine methylsulfate 2.5 milligram/1 milliliter conventional release solution for injection (clinical drug)

• SNOMED CT Concept\produit pharmaceutique ou biologique\Medicinal product (product)\...
• \Medicinal product categorized by disposition (product)\inhibiteur enzymatique\Product containing acetylcholinesterase inhibitor (product)\Product containing reversible anticholinesterase (product)\Product containing neostigmine (medicinal product)\Glycopyrronium- and neostigmine-containing product\Glycopyrronium and neostigmine only product\Product containing only glycopyrronium and neostigmine in parenteral dose form (medicinal product form)\Glycopyrrolate 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection
• \Medicinal product categorized by disposition (product)\inhibiteur enzymatique\Product containing acetylcholinesterase inhibitor (product)\Product containing reversible anticholinesterase (product)\Product containing neostigmine (medicinal product)\Glycopyrronium- and neostigmine-containing product\Glycopyrronium- and neostigmine-containing product in parenteral dose form\Product containing only glycopyrronium and neostigmine in parenteral dose form (medicinal product form)\Glycopyrrolate 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection
• \Medicinal product categorized by disposition (product)\inhibiteur enzymatique\Product containing acetylcholinesterase inhibitor (product)\Product containing reversible anticholinesterase (product)\Product containing neostigmine (medicinal product)\Product containing neostigmine in parenteral dose form (medicinal product form)\Glycopyrronium- and neostigmine-containing product in parenteral dose form\Product containing only glycopyrronium and neostigmine in parenteral dose form (medicinal product form)\Glycopyrrolate 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection
• \Medicinal product categorized by disposition (product)\Product containing acetylcholine receptor antagonist (product)\Product containing muscarinic receptor antagonist (product)\Glycopyrronium-containing product\Glycopyrronium- and neostigmine-containing product\Glycopyrronium and neostigmine only product\Product containing only glycopyrronium and neostigmine in parenteral dose form (medicinal product form)\Glycopyrrolate 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection
• \Medicinal product categorized by disposition (product)\Product containing acetylcholine receptor antagonist (product)\Product containing muscarinic receptor antagonist (product)\Glycopyrronium-containing product\Glycopyrronium- and neostigmine-containing product\Glycopyrronium- and neostigmine-containing product in parenteral dose form\Product containing only glycopyrronium and neostigmine in parenteral dose form (medicinal product form)\Glycopyrrolate 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection
• \Medicinal product categorized by disposition (product)\Product containing acetylcholine receptor antagonist (product)\Product containing muscarinic receptor antagonist (product)\Glycopyrronium-containing product\Glycopyrronium-containing product in parenteral dose form\Glycopyrronium- and neostigmine-containing product in parenteral dose form\Product containing only glycopyrronium and neostigmine in parenteral dose form (medicinal product form)\Glycopyrrolate 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection
• \Medicinal product categorized by structure\Nitrogen and/or nitrogen compound-containing product\Product containing quaternary ammonium compound (product)\Glycopyrronium-containing product\...
• \Glycopyrronium- and neostigmine-containing product\Glycopyrronium and neostigmine only product\Product containing only glycopyrronium and neostigmine in parenteral dose form (medicinal product form)\Glycopyrrolate 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection
• \Glycopyrronium- and neostigmine-containing product\Glycopyrronium- and neostigmine-containing product in parenteral dose form\Product containing only glycopyrronium and neostigmine in parenteral dose form (medicinal product form)\Glycopyrrolate 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection
• \Glycopyrronium-containing product in parenteral dose form\Glycopyrronium- and neostigmine-containing product in parenteral dose form\Product containing only glycopyrronium and neostigmine in parenteral dose form (medicinal product form)\Glycopyrrolate 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection
• \Product manufactured as parenteral dose form (product)\Glycopyrronium-containing product in parenteral dose form\Glycopyrronium- and neostigmine-containing product in parenteral dose form\Product containing only glycopyrronium and neostigmine in parenteral dose form (medicinal product form)\Glycopyrrolate 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection
• \Product manufactured as parenteral dose form (product)\Product containing neostigmine in parenteral dose form (medicinal product form)\Glycopyrronium- and neostigmine-containing product in parenteral dose form\Product containing only glycopyrronium and neostigmine in parenteral dose form (medicinal product form)\Glycopyrrolate 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection
• \médicament pour le système nerveux autonome\Parasympathomimetic agent-containing product\Product containing acetylcholinesterase inhibitor (product)\Product containing reversible anticholinesterase (product)\Product containing neostigmine (medicinal product)\Glycopyrronium- and neostigmine-containing product\Glycopyrronium and neostigmine only product\Product containing only glycopyrronium and neostigmine in parenteral dose form (medicinal product form)\Glycopyrrolate 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection
• \médicament pour le système nerveux autonome\Parasympathomimetic agent-containing product\Product containing acetylcholinesterase inhibitor (product)\Product containing reversible anticholinesterase (product)\Product containing neostigmine (medicinal product)\Glycopyrronium- and neostigmine-containing product\Glycopyrronium- and neostigmine-containing product in parenteral dose form\Product containing only glycopyrronium and neostigmine in parenteral dose form (medicinal product form)\Glycopyrrolate 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection
• \médicament pour le système nerveux autonome\Parasympathomimetic agent-containing product\Product containing acetylcholinesterase inhibitor (product)\Product containing reversible anticholinesterase (product)\Product containing neostigmine (medicinal product)\Product containing neostigmine in parenteral dose form (medicinal product form)\Glycopyrronium- and neostigmine-containing product in parenteral dose form\Product containing only glycopyrronium and neostigmine in parenteral dose form (medicinal product form)\Glycopyrrolate 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection
• \médicament pour le système nerveux autonome\Product containing acetylcholine receptor antagonist (product)\Product containing muscarinic receptor antagonist (product)\Glycopyrronium-containing product\Glycopyrronium- and neostigmine-containing product\Glycopyrronium and neostigmine only product\Product containing only glycopyrronium and neostigmine in parenteral dose form (medicinal product form)\Glycopyrrolate 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection
• \médicament pour le système nerveux autonome\Product containing acetylcholine receptor antagonist (product)\Product containing muscarinic receptor antagonist (product)\Glycopyrronium-containing product\Glycopyrronium- and neostigmine-containing product\Glycopyrronium- and neostigmine-containing product in parenteral dose form\Product containing only glycopyrronium and neostigmine in parenteral dose form (medicinal product form)\Glycopyrrolate 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection
• \médicament pour le système nerveux autonome\Product containing acetylcholine receptor antagonist (product)\Product containing muscarinic receptor antagonist (product)\Glycopyrronium-containing product\Glycopyrronium-containing product in parenteral dose form\Glycopyrronium- and neostigmine-containing product in parenteral dose form\Product containing only glycopyrronium and neostigmine in parenteral dose form (medicinal product form)\Glycopyrrolate 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core

Descriptions:

Id	Description	Lang	Type	Status	Case?	Module
3752320013	Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection	en	Synonym (core metadata concept)	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
3752321012	Glycopyrrolate 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection	en	Synonym (core metadata concept)	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
3752322017	Product containing precisely glycopyrronium bromide 500 microgram/1 milliliter and neostigmine methylsulfate 2.5 milligram/1 milliliter conventional release solution for injection (clinical drug)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core

Expanded Value Set

Reference Sets

Canada English language reference set (foundation metadata concept)

GB English

US English

Back to Start